Jan. 22 at 3:00 PM
📈
$TNON just turned in its best-ever Q3, posting
$1.2M in revenue, up 32% YoY, driven by healthy Catamaran SI joint fusion demand and early SImmetry contributions.
🦴 The roadmap continues with the SImmetry+ alpha launch targeted for Q4 2025, expanding Tenon’s sacro-pelvic product suite.
💰 On the capital front, the company secured
$2.85M in PIPE financing from industry-friendly investors post-earnings.
👀 With momentum building across products and funding, is Tenon finally approaching an inflection point? https://www.zacks.com/stock/quote/TNON/?cid=sm-stocktwits-0-quote_overview-oc-29979&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_29979